These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6643655)

  • 1. Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks.
    Barry AL; Gavan TL; Jones RN
    J Clin Microbiol; 1983 Nov; 18(5):1051-4. PubMed ID: 6643655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.
    Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1980 Sep; 18(3):487-90. PubMed ID: 7425615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin.
    Dornbusch K
    Scand J Infect Dis Suppl; 1980; Suppl 23():46-53. PubMed ID: 6937968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1979 Jun; 15(6):834-5. PubMed ID: 475365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
    Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
    Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
    Barry AL; Miller GH; Hare RS; Jones RN; Thornsberry C
    J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro comparison of gentamicin and netilmicin including a regression line for netilmicin.
    Bang J; Mortensen I; Bentzon MW
    Scand J Infect Dis Suppl; 1980; Suppl 23():34-8. PubMed ID: 6782656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
    Barry AL; Jones RN; Gavan TL
    J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of benzylpenicillin and gentamicin/netilmicin on Streptococcus faecalis.
    Mortensen I
    Scand J Infect Dis Suppl; 1980; Suppl 23():59-61. PubMed ID: 6782658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of 327 clinical isolates to netilmicin.
    Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K
    J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute.
    Barry AL; Creitz L; Packer RR
    J Clin Microbiol; 1985 Mar; 21(3):409-14. PubMed ID: 3980691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.
    Barry AL; Miller GH; Hare RS; Thornsberry C; Jones RN
    Eur J Clin Microbiol; 1987 Aug; 6(4):416-7. PubMed ID: 3117533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of netilmicin against Nocardia.
    Martin-Luengo F; Valero-Guillen PL
    J Antimicrob Chemother; 1983 Oct; 12(4):413-4. PubMed ID: 6643336
    [No Abstract]   [Full Text] [Related]  

  • 19. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.
    Pfaller MA; Barry A; Bille J; Brown S; Ellis D; Meis JF; Rennie R; Rinaldi M; Rogers T; Traczewski M
    J Clin Microbiol; 2004 Apr; 42(4):1716-8. PubMed ID: 15071030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.